Navigation Links
Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
Date:3/16/2010

mmission (the "SEC") on December 3, 2007. A  final prospectus supplement related to the offering has been filed with the SEC and is available on the SEC's Web site at http://www.sec.gov. Copies of the final prospectus supplement relating to these securities may be obtained from Jefferies & Company, Inc., Attention: Syndicate Prospectus Department, 520 Madison Avenue, New York, NY, 10022 and at (888) 449-2342. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia, and other neurological and endocrine-related diseases and disorders.

In addition to hi
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
2. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
3. Neurocrine Biosciences to Present at the Bear Stearns Healthcare Conference
4. Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference
5. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2007 Financial Results
7. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
8. Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update
9. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
10. Neurocrine Announces Work Force Restructuring
11. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... , Nov. 18, 2014  Novira Therapeutics, Inc., ... curative treatment of chronic hepatitis B virus (HBV) infection, ... was appointed to its Scientific Advisory Board (SAB).  ... our SAB," said Christian S. Schade , Chief ... clinical development experience which will be invaluable to Novira ...
(Date:11/16/2014)... MA (PRWEB) November 16, 2014 James ... Renovation With Filtered Fume Hoods, 3 Years Later” scheduled ... the fall of 2011, Butler University surprised many in ... hoods in their organic chemistry and general chemistry teaching ... shortcomings due to building age and substantial growth within ...
(Date:11/15/2014)... 14, 2014 The International ... today that the society’s Governing Board has grown ... Lifesciences chief scientific officer and Dr. Charles Simonton, ... Abbott Vascular. Mr. Rowe and Dr. Simonton ... development experts. , Dr. Nabil Dib, ISCTR ...
(Date:11/15/2014)... Washington, PA (PRWEB) November 14, 2014 ... health continuing medical education (CME), today announced the launch ... fibrocystic breast changes (FBC). Breast pain is the ... physician. Approximately 45% of all women report mild breast ... women experience FBC across their lifespan. Along with breast ...
Breaking Biology Technology:Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3Don't miss the I2SL High-Tech Talks Webinar Series Presenting: Butler University's Renovation With Filtered Fume Hoods, 3 Years Later 2Don't miss the I2SL High-Tech Talks Webinar Series Presenting: Butler University's Renovation With Filtered Fume Hoods, 3 Years Later 3International Society for Cardiovascular Translational Research Governing Board Adds Medical Industry Leaders 2Omnia Education Launches Nationwide Educational Series on Breast Pain and Fibrocystic Breast Changes Affecting Half of all Women 2Omnia Education Launches Nationwide Educational Series on Breast Pain and Fibrocystic Breast Changes Affecting Half of all Women 3
... 25, 2012 Aviir Diagnostic Laboratory announced today ... with MultiPlan, Inc. for ancillary diagnostics laboratory testing. ... PHCS and PHCS Savility Networks. Aviir ... from the Stanford University School of Medicine to ...
... The rise of the corporate venture fund and the ... themes at BioTrinity, the-premier European biopartnering and investment conference ... comprehensive support for bioscience businesses in the Oxford and ... day of the conference saw senior figures from Merck ...
... well-respected, independent, third-party laboratory has tested for Tuberculosis (TB) ... (BioNanoPore) test kits and achieved the detection of ... culture times for conventional technologies take a minimum of ... concurrent tests for TB at the same facility, using ...
Cached Biology Technology:Aviir Laboratories Announce National Agreement With MultiPlan 2Corporate Venturing and Early-Stage Financing in the Spotlight at BioTrinity 2Corporate Venturing and Early-Stage Financing in the Spotlight at BioTrinity 3NanoLogix Provides Testing and Operations Update 2NanoLogix Provides Testing and Operations Update 3
(Date:11/3/2014)... , Nov. 3, 2014  NeuroSigma ® ... -based life sciences company focused on commercialization of ... for the treatment of neurological and neuropsychiatric ... Industrial Property has issued a Notice of Allowance ... application is co-owned by NeuroSigma and the Regents ...
(Date:11/2/2014)... a child, it was fascinating to put a flashlight ... through the hand. Washington University in St. Louis engineers ... the body,s tissues to improve imaging of cancerous tissues ... PhD, the Gene K. Beare Distinguished Professor of Biomedical ... is applying a novel time-reversal technology that allows researchers ...
(Date:10/31/2014)... that endangered musk deer still live in Nuristan Province ... by poachers: Musk deer scent glands are more valuable ... of the journal Oryx , NEW YORK ... its last confirmed sighting, a strange deer with vampire-like ... northeast Afghanistan according to a research team led by ...
Breaking Biology News(10 mins):NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3Improving imaging of cancerous tissues by reversing time 2Strange, fanged deer persists in Afghanistan 2
... a molecule that plays a role in the battle plants ... for lunch. The group led by Professor Clarence A. "Bud" ... act like a hormone, signaling to the rest of the ... an infection. They also discovered the receptor protein to which ...
... Researchers have developed a new technique for creating human ... embryonic stem cells. The fusion causes the adult cells ... have the developmental characteristics of human embryonic stem cells. ... somatic cell nuclear transfer (SCNT), a method that is ...
... in prehistoric rocks suggest Earth was not ice-bound , ... rock formations has turned up strong evidence on the ... The study appears in the Sept. 29 Science Express. ... of earth sciences in the USC College of Letters, ...
Cached Biology News:A new molecule discovered in the battle between plants and disease 2Researchers devise new technique for creating human stem cells 2Researchers devise new technique for creating human stem cells 3Researchers devise new technique for creating human stem cells 4Study casts doubt on 'Snowball Earth' theory 2
Mouse monoclonal [4i97] to HLA Class 1 A25 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 1 Antigen-A25. Swiss Protein ID: P18462...
... Contact Printing Kit contains choice of Printing Surface (3 ... over Ti adhesion layer, 1 silicon wafer coated with ... 3 plain glass slides) and PDMS Stamps (3 PDMS ... squares or 100 um x 10 mm or 200 ...
Human Dectin-1/CLEC7A Biotinylated Affinity Purified PAb...
Raf-1 (C-12)-G...
Biology Products: